135 related articles for article (PubMed ID: 22178231)
1. Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis.
Lin HY; Yang MC; Huang CH; Wu WJ; Yu TJ; Lung FW
Urol Oncol; 2013 Oct; 31(7):1231-41. PubMed ID: 22178231
[TBL] [Abstract][Full Text] [Related]
2. p53 codon 72 polymorphism was associated with vulnerability, progression, but not prognosis of bladder cancer in a Taiwanese population: an implication of structural equation modeling to manage the risks of bladder cancer.
Lin HY; Huang CH; Yu TJ; Wu WJ; Yang MC; Lung FW
Urol Int; 2011; 86(3):355-60. PubMed ID: 21346315
[TBL] [Abstract][Full Text] [Related]
3. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S
Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis.
Pineda S; Milne RL; Calle ML; Rothman N; López de Maturana E; Herranz J; Kogevinas M; Chanock SJ; Tardón A; Márquez M; Guey LT; García-Closas M; Lloreta J; Baum E; González-Neira A; Carrato A; Navarro A; Silverman DT; Real FX; Malats N
PLoS One; 2014; 9(5):e89952. PubMed ID: 24818791
[TBL] [Abstract][Full Text] [Related]
5. Association of TP53 gene polymorphisms with susceptibility of bladder cancer in Bangladeshi population.
Hosen MB; Salam MA; Islam MF; Hossain A; Hawlader MZ; Kabir Y
Tumour Biol; 2015 Aug; 36(8):6369-74. PubMed ID: 25801242
[TBL] [Abstract][Full Text] [Related]
6. hOGG1 Ser326Cys polymorphism is associated with risk of bladder cancer in a Chinese population: a case-control study.
Ma L; Chu H; Wang M; Shi D; Zhong D; Li P; Tong N; Yin C; Zhang Z
Cancer Sci; 2012 Jul; 103(7):1215-20. PubMed ID: 22463382
[TBL] [Abstract][Full Text] [Related]
7. TP53 alterations and colorectal cancer predisposition in south Indian population: a case-control study.
Singamsetty GK; Malempati S; Bhogadhi S; Kondreddy R; Govatati S; Tangudu NK; Govatati S; kuraganti AK; Bhanoori M; Kassetty K
Tumour Biol; 2014 Mar; 35(3):2303-11. PubMed ID: 24158910
[TBL] [Abstract][Full Text] [Related]
8. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
[TBL] [Abstract][Full Text] [Related]
9. The genetic association between PON1 polymorphisms and osteonecrosis of femoral head: A case-control study.
Li JM; Li Y; Wang L
Medicine (Baltimore); 2017 Oct; 96(42):e8198. PubMed ID: 29049204
[TBL] [Abstract][Full Text] [Related]
10. Association of nineteen polymorphisms from seven DNA repair genes and the risk for bladder cancer in Gansu province of China.
Zhu G; Su H; Lu L; Guo H; Chen Z; Sun Z; Song R; Wang X; Li H; Wang Z
Oncotarget; 2016 May; 7(21):31372-83. PubMed ID: 27153553
[TBL] [Abstract][Full Text] [Related]
11. GABRB2 Haplotype Association with Heroin Dependence in Chinese Population.
Kim YS; Yang M; Mat WK; Tsang SY; Su Z; Jiang X; Ng SK; Liu S; Hu T; Pun F; Liao Y; Tang J; Chen X; Hao W; Xue H
PLoS One; 2015; 10(11):e0142049. PubMed ID: 26561861
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of p53 codon 72 and bladder cancer susceptibility: a hospital-based case-control study.
Zhang R; Chen W; Zhang W; Jiang Q; Liu C; Lin Y; Hu Z; Yu S; Xu G
Genet Test Mol Biomarkers; 2011 May; 15(5):337-41. PubMed ID: 21291320
[TBL] [Abstract][Full Text] [Related]
13. Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population.
Jaiswal PK; Singh V; Srivastava P; Mittal RD
Gene; 2013 Apr; 519(1):128-34. PubMed ID: 23403235
[TBL] [Abstract][Full Text] [Related]
14. Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer.
Pouladi N; Abdolahi S; Farajzadeh D; Hosseinpour Feizi MA
PLoS One; 2019; 14(8):e0220727. PubMed ID: 31387111
[TBL] [Abstract][Full Text] [Related]
15. Influence of tumour suppressor gene (TP53, BRCA1 and BRCA2) polymorphisms on polycystic ovary syndrome in South Indian women.
Siddamalla S; Reddy TV; Govatati S; Guruvaiah P; Deenadayal M; Shivaji S; Bhanoori M
Eur J Obstet Gynecol Reprod Biol; 2018 Aug; 227():13-18. PubMed ID: 29860059
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in PEDF linked with the susceptibility to age-related macular degeneration: A case-control study.
Hao X; Cheng J; Zhang Z
Medicine (Baltimore); 2018 Aug; 97(34):e11981. PubMed ID: 30142832
[TBL] [Abstract][Full Text] [Related]
17. Significant association of caveolin-1 genotypes with bladder cancer susceptibility in Taiwan.
Bau DT; Chang CH; Tsai RY; Wang HC; Wang RF; Tsai CW; Yao CH; Chen YS; Shyue SK; Huang CY
Chin J Physiol; 2011 Jun; 54(3):153-60. PubMed ID: 21789897
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.
Ru JY; Cong Y; Kang WB; Yu L; Guo T; Zhao JN
Int J Clin Exp Pathol; 2015; 8(3):3198-203. PubMed ID: 26045840
[TBL] [Abstract][Full Text] [Related]
19. Association of p53 codon 248 (exon7) with urinary bladder cancer risk in the North Indian population.
Jaiswal PK; Goel A; Mittal RD
Biosci Trends; 2011; 5(5):205-10. PubMed ID: 22101376
[TBL] [Abstract][Full Text] [Related]
20. Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study.
Lung FW; Shu BC; Kao WT; Chen CN; Ku YC; Tzeng DS
BMC Med Genet; 2009 Dec; 10():147. PubMed ID: 20040103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
